These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2856592)

  • 21. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Wexler HM; Engel AE; Glass D; Li C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
    Marina M; Ivanova M; Kantardjiev T
    Anaerobe; 2009 Aug; 15(4):127-32. PubMed ID: 19292999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymicrobial etiology of dental caries.
    Saini S; Mahajan A; Sharma JK; Arora ; Saini OP
    Indian J Pathol Microbiol; 1999 Jan; 42(1):25-9. PubMed ID: 10420681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
    Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests.
    Fuchs PC; Barry AL; Brown SD
    J Antimicrob Chemother; 1999 May; 43(5):703-6. PubMed ID: 10382893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria.
    Murray PR; Jones RN; Allen SD; Erwin ME; Fuchs PC; Gerlach EH
    Diagn Microbiol Infect Dis; 1993; 16(3):191-203. PubMed ID: 8477573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Common pathogens of surgical infections and their drug sensitivities].
    Zhang YP
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):215-6, 253. PubMed ID: 2805989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):919-24. PubMed ID: 2512142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The aerobic activity of metronidazole against anaerobic bacteria.
    Dione N; Khelaifia S; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2015 May; 45(5):537-40. PubMed ID: 25813393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
    Montiel F; Kaltwasser G; Pinto ME; Lam M
    Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity of aerobic bacteria and Candida species to chlormidazole hydrochloride in vitro].
    Krasiejko I; Gajewicz L; Lipnicki D
    Pol Tyg Lek; 1990 Jan 22-29; 45(4-5):91-2. PubMed ID: 2395759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Hydroxyisocaproic acid (HICA): a new potential topical antibacterial agent.
    Sakko M; Tjäderhane L; Sorsa T; Hietala P; Järvinen A; Bowyer P; Rautemaa R
    Int J Antimicrob Agents; 2012 Jun; 39(6):539-40. PubMed ID: 22483561
    [No Abstract]   [Full Text] [Related]  

  • 37. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
    Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
    Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial therapy of anaerobic infections, 1991.
    Sanders CV; Aldridge KE
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):72S-79S. PubMed ID: 2041835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative
    Goldstein EJC; Citron DM; Tyrrell KL; Leoncio E; Merriam CV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in-vitro activity of biapanem against 964 clinical isolates of aerobic bacteria.
    Raymond NJ; Bremner DA
    J Antimicrob Chemother; 1995 May; 35(5):681-6. PubMed ID: 7592182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.